BITPRISMIA
MEI Pharma, a Nasdaq-listed company, has acquired $100 million worth of Litecoin (LTC) as part of its treasury strategy, signaling growing corporate interest in cryptocurrencies beyond the tech sector.
MEI Pharma's decision to hold $100 million worth of Litecoin in its treasury marks a significant step in corporate crypto adoption, signaling potential mainstream acceptance and influencing the cryptocurrency market.